Literature DB >> 28528423

Rapid resolution of leptomeningeal disease with targeted therapy in a metastatic melanoma patient.

Isabella C Glitza1, Sherise D Ferguson2, Nandita Guha-Thakurta3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28528423     DOI： 10.1007/s11060-017-2472-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  3 in total

1.  Cerebrospinal fluid concentrations of vemurafenib in patients treated for brain metastatic BRAF-V600 mutated melanoma.

Authors:  Lilia Sakji-Dupré; Emilie Le Rhun; Carole Templier; Eve Desmedt; Benoit Blanchet; Laurent Mortier
Journal:  Melanoma Res       Date:  2015-08       Impact factor: 3.599

2.  Targeted treatment and immunotherapy in leptomeningeal metastases from melanoma.

Authors:  M H Geukes Foppen; D Brandsma; C U Blank; J V van Thienen; J B Haanen; W Boogerd
Journal:  Ann Oncol       Date:  2016-03-08       Impact factor: 32.976

3.  Neoplastic leptomeningitis presenting in a melanoma patient treated with dabrafenib (a V600EBRAF inhibitor): a case report.

Authors:  Ester Simeone; Eleonora De Maio; Fabio Sandomenico; Franco Fulciniti; Secondo Lastoria; Pasquale Aprea; Stefania Staibano; Vincenzo Montesarchio; Giuseppe Palmieri; Nicola Mozzillo; Paolo A Ascierto
Journal:  J Med Case Rep       Date:  2012-05-17
  3 in total
  4 in total

1.  Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).

Authors:  Sherise D Ferguson; Shivani Bindal; Roland L Bassett; Lauren E Haydu; Ian E McCutcheon; Amy B Heimberger; Jing Li; Barbara J O'Brien; Nandita Guha-Thakurta; Michael T Tetzlaff; Hussein Tawbi; Michael A Davies; Isabella C Glitza
Journal:  J Neurooncol       Date:  2019-03-07       Impact factor: 4.130

Review 2.  Leptomeningeal Metastases: New Opportunities in the Modern Era.

Authors:  Jessica A Wilcox; Min Jun Li; Adrienne A Boire
Journal:  Neurotherapeutics       Date:  2022-07-05       Impact factor: 7.620

Review 3.  Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma.

Authors:  Yolanda Piña; Sirisha Yadugiri; Debra N Yeboa; Sherise D Ferguson; Peter A Forsyth; Isabella C Glitza Oliva
Journal:  Curr Oncol Rep       Date:  2022-01-20       Impact factor: 5.075

Review 4.  Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations-Chances and Challenges.

Authors:  Marvin Kuske; Ricarda Rauschenberg; Marlene Garzarolli; Michelle Meredyth-Stewart; Stefan Beissert; Esther G C Troost; Oliva Isabella Claudia Glitza; Friedegund Meier
Journal:  Am J Clin Dermatol       Date:  2018-08       Impact factor: 7.403
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.